Medical devices and advanced therapies: formulation and regulatory aspects

Course objectives

General objectives The lessons and seminar activities contribute to the development of the following skills: - know the problems of formulation, production and control of biotechnological medicines, biosimilars and advanced therapies, with particular attention to the relevant national and international standards; - know the formulation, production and control issues of medical devices with particular attention to the relevant national and international standards; - evaluate the use of the categories presented during the course according to the principles of quality, safety and economic sustainability. Specific objectives, upon completion of the course Knowledge and understanding of - basic elements related to the formulation, preparation, classification and control of biotechnological and biosimilar medicinal products; - basic elements related to the formulation of advanced therapies; - national and international regulatory aspects of the formulation, preparation, classification, control, marketing and supervision of biotechnological medicines, biosimilars and medical devices. Ability to apply knowledge and understanding: - to follow the main stages of production control of biotechnological and biosimilar medicinal products, with particular regard to regulatory problems and their safety; - to follow the main phases of the development of advanced therapies, with particular regard to regulatory problems and their safety; - to be able to apply the knowledge of the European Directives on Medical Devices and Medical Devices for in Vitro Diagnostics, to the regulatory and qualitative activity within a supplier or manufacturer of one of these Devices, but also at the base of the working activity of Entities that have to evaluate the latter. - to develop knowledge and skills suitable for a correct evaluation, selection, information and use in compliance with current legislation and the clinical needs of patients of the products in question. Judgment autonomy The lessons and seminar activities allow the student to: - evaluate the managerial, technological and practical aspects related to the preparation, production, control, distribution and sale of biotechnological medicines, biosimilars and medical devices; - identify and evaluate the risks related to the control of advanced therapy, biotechnological medicines, biosimilars and medical devices; Communication skills During the course there will be moments of comparison and debate, coordinated by the teacher, aimed at verifying the ability to communicate/transmit what the student has learned. Furthermore, these moments are fundamental for the development of critical evaluation and reasoning skills by the student which will allow him to report, in the exercise of the profession, information, advice and solutions to specialist and non-specialist interlocutors. Self-learning ability The tools provided during the course allow the student to enter the world of work thanks to the set of knowledge to deal with both the professional practice in pharmacy and the sequence of the production and control process of biotechnological medicines, biosimilars and medical devices. Knowledge of the legislation, which is constantly evolving, and the socio-economic aspects represent an indispensable step in the training process of the student in Pharmacy. The knowledge acquired during the course therefore constitutes essential and strongly characterizing training elements for the exercise of the profession of pharmacist in the various working environments.

Channel 1
MARIA CARAFA Lecturers' profile

Program - Frequency - Exams

Prerequisites
The student must possess a) Good command of specific technical terminology. b) In order to understand the contents of the lessons and achieve the learning objectives, the student must have acquired and assimilated the basic concepts relating to a course of General and Inorganic Chemistry, Organic Chemistry, Physics at university level Furthermore, an in-depth study of the basic concepts of pharmaceutical technology and legislation is suggested. However, some of these aspects will be recalled at the beginning of the course.
Frequency
Course attendance is mandatory
Exam mode
The exam includes an oral test whose purpose is to evaluate the study of the subject and the understanding of the basic topics and the ability to connect different aspects covered during the course. To pass the test it is necessary to acquire a grade of 18/30, demonstrating that you have the minimum knowledge and basic skills of the topics relating to the production, control and dispensing of biotechnological and biosimilar medicines and to be able to deal with both the professional practice in the pharmacy and the processes of the medicines production and control process.
CARLOTTA MARIANECCI Lecturers' profile

Program - Frequency - Exams

Course program
General overview of dm, differences with drugs, substance-based dm, Clinical investigations with dm and IVD, Conformity assessment procedures and Notified Bodies, Surveillance and supervision, The role of Notified Bodies, The audit activities, Technical product dossier evaluation and risk management assessment, Biological safety assessment, Classification rules, Technological aspects of dm development, The world of dm, Advertising on dm.
Prerequisites
The course is intended for students who have at least taken a course in Pharmaceutical Technology and are therefore familiar with the definition of a drug and have had some initial contact with the study of pharmaceutical regulations.
Books
Given the recent entry into force of the new Regulation, there are not many texts available that deal specifically with DMs. Therefore, reference is made to Regulation (EU) 2017/745 and Regulation (EU) 2017/746 in addition to Legislative Decree 137/2022
Frequency
Compulsory attendance at face-to-face classes
Exam mode
The final exam will be oral and will involve the discussion of a ppt oral presentation on a DM of the student's choice in which the aspects highlighted in the course must be presented. After the presentation, the student will have to answer questions formulated by the lecturer designed to test his or her preparation. A grade of not less than 18/30 must be achieved to pass the exam. The student must demonstrate that he or she has acquired sufficient knowledge of the topics covered during the lectures, a basic knowledge of the proposed normative topics, and is able to independently identify a topic on which he or she can then develop a ppt oral presentation dealing with the selected topic, taking into account what was learned in class. To achieve a score of 30/30 cum laude, on the other hand, the student must demonstrate excellent knowledge of all the topics covered during the course, being able to connect them in a logical and coherent manner.
  • Lesson code10612123
  • Academic year2025/2026
  • CoursePharmacy
  • CurriculumCurriculum unico
  • Year3rd year
  • Semester1st semester
  • SSDCHIM/09
  • CFU6